Table 2.
Component | Function in Vaccines | Relevant Vaccines | Allergic Reactions | Ref. |
---|---|---|---|---|
Gelatin | Stabilizer | MMR and varicella | Anaphylaxis and urticaria |
[24,25] |
Egg protein (albumin) | Residual medium and stabilizer | MMR, influenza, and yellow fever | Anaphylaxis | [10,29] |
Milk protein (casein) | Medium nutrient | DTaP | Anaphylaxis | [34] |
Thimerosal | Preservative | Influenza and Td | Local reaction | [35,36] |
Aluminum | Adjuvant | DTaP, Hib, hepatitis A/B, HPV, Japanese encephalitis, meningococcal, pneumococcal, and Tdap | Local reaction | [10] |
Neomycin | Antimicrobial | DTaP, hepatitis A, influenza, MMR, polio, and varicella | Anaphylaxis | [38] |
Phenoxyethanol | Preservative | DTaP, influenza, polio, and Tdap | Local reaction | [39] |
Latex | Pharmaceutical closure | DTaP, hepatitis A/B, influenza, meningococcal, rotavirus, Tdap, Td, and yellow fever | Anaphylaxis and urticaria |
[40,41] |
Yeast | Medium nutrient | DTaP, hepatitis B, HPV, meningococcal, and pneumococcal | Anaphylaxis | [10,42] |
Dextran | Medium nutrient and stabilizer | MMR a and rotavirus | Anaphylaxis | [43] |
Polyethylene glycol | Surfactant of mRNA | COVID-19 | Anaphylaxis | [44,45,46] |
a MMR vaccines containing dextran have been withdrawn from the market. MMR, measles–mumps–rubella; DTaP, diphtheria–tetanus–acellular pertussis; Td, tetanus–diphtheria; Tdap, tetanus-diphtheria-acellular pertussis; Hib, Hemophilus influenzae type b; HPV, human papillomavirus.